Unique ID issued by UMIN | UMIN000002218 |
---|---|
Receipt number | R000002725 |
Scientific Title | A randomized trial to assess the effects of hydrogen-ride dissolution water for the patients with mild cognitive impairment (MCI). |
Date of disclosure of the study information | 2009/07/17 |
Last modified on | 2013/04/01 22:45:46 |
A randomized trial to assess the effects of hydrogen-ride dissolution water for the patients with mild cognitive impairment (MCI).
An interventional trial for MCI using hydrogen-ride water.
A randomized trial to assess the effects of hydrogen-ride dissolution water for the patients with mild cognitive impairment (MCI).
An interventional trial for MCI using hydrogen-ride water.
Japan |
mild cognitive impairment
Psychiatry |
Others
NO
To examine whether hydrogen dissolution water is superior to water (placebo) in prevention of cognitive decline among patients with MCI.
Safety,Efficacy
Exploratory
Pragmatic
Phase II,III
Score in Japanese version of ADAS-Cog and Mini Mental State Examination.
Scores in Japanese version of ADCS-ADL, MRI and SPCET imaging, and Geriatric Depression Scale.
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
YES
Institution is considered as a block.
YES
Central registration
2
Prevention
Food |
The patients of hydrogen group will be intervened with 500ml hydrogen dissolution water every-day for 2 years.
The patients of placebo group will be intervened with 500ml ordinary water every-day for 2 years.
67 | years-old | <= |
Not applicable |
Male and Female
1) Participants of the Tone project.
2) Being able to give a written informed consent to the participation in the present study.
3) Having diagnosis of the mild cognitive impairment.
4) Being able to observe the following requirement: good compliance with the water; participation in the scheduled examinations for assessment; keeping a log-diary recording the consumption of the water.
5) Having a modified Hachinski Ischemic score of 4 or less.
6) Having the 15-item Geriatric Depression Scale score of 6 or less.
1) Meeting DSM-IV TR criteria for dementing illnesses.
2) Having serious or unstable illnesses.
3) Having a history within past 5 years of serious infectious disease affecting the brain and/or malignant diseases.
4) Having a history of alcohol or drug abuse or dependence (on DSM-IV TR) within the past 5 years.
5) Receiving any types of anti-Alzheimer drugs.
6) Recent (within 4 weeks) initiation of medications that affect the central nervous system.
120
1st name | |
Middle name | |
Last name | Takashi Asada |
University of Tsukuba
Department of Neuropsychiatry, Institute of Clinical Medicine
1-1-1, Tennodai, Tsukuba City, Ibaraki-prefecture, Japan
+81(29)853-3178
1st name | |
Middle name | |
Last name | Takashi Asada |
University of Tsukuba
Department of Neuropsychiatry, Institute of Clinical Medicine
1-1-1, Tennodai, Tsukuba City, Ibaraki-prefecture
tasada@md.tsukuba.ac.jp
Department of Neuropsychiatry, Institute of Clinical Medicine University of Tsukuba
Department of Neuropsychiatry, Institute of Clinical Medicine University of Tsukuba
Self funding
Japan
NO
2009 | Year | 07 | Month | 17 | Day |
Unpublished
Completed
2009 | Year | 06 | Month | 01 | Day |
2009 | Year | 07 | Month | 01 | Day |
2012 | Year | 01 | Month | 01 | Day |
2012 | Year | 08 | Month | 10 | Day |
2012 | Year | 08 | Month | 10 | Day |
2012 | Year | 10 | Month | 30 | Day |
2009 | Year | 07 | Month | 17 | Day |
2013 | Year | 04 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002725